Article
Interpretable Machine Learning for Proteomics-Based Subtyping and Tumor Mutational Burden Prediction in Endometrial Cancer.
Proteomics. Clinical applications - 1 Nov 2025
Luong Thi-My-Trang, Bui Xuan Lam, Tzeng Chii-Ruey, Le Nguyen Quoc Khanh
Abstract excerpt
BACKGROUND: Endometrial carcinoma (EC) represents a significant clinical challenge due to its pronounced molecular heterogeneity, directly influencing prognosis and therapeutic responses. Accurate classification of molecular subtypes (CNV-high, CNV-low, MSI-H, POLE) and precise tumor mutational burden (TMB) assessment is crucial for guiding personalized therapeutic interventions. Integrating proteomics data with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
